Dariusz P. Olszyna1,2, Annelies Verbon2, John P. Pribble3, Terence Turner3, Tim Axtelle3, Sander J. H. van Deventer1, Tom van der Poll1,2
European Cytokine Network, Vol.14, No.3, pp. 158-162, 2003
Abstract To determine the role of CD14 in lipopolysaccharide (LPS)-induced release of chemokines,
16 humans were injected with LPS (4 ng/kg) preceded (– 2 h) by intravenous IC14, an anti-human
CD14 monoclonal antibody, or placebo. LPS elicited increases in interleukin (IL)-8 concentrations in plasma and
in lysates of red blood cell (RBC), polymorphonuclear cell and mononuclear cell fractions, which were all reduced
by IC14. LPS also induced rises in the plasma and RBC levels of monocyte chemoattractant protein (MCP)-1,
which were diminished by IC14. Macrophage inflammatory protein (MIP)-1a and MIP-1β, chemokines that in
contrast to IL-8 More >